Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q3 2017 call → NOWe need to determine if management's forward account consists of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company already supplies or serves. The key is that management speaks about counterparties' business as part of its own, the company is already inside that growth, and the counterparties' trajectory is early and large relative to the company. Looking at the transcript, management discusses several initiatives: loyalty program test, social media influencers, Amazon Prime Now partnership, new brands, etc. The Amazon Prime Now partnership is a specific counterparty. Management says: "we recently partnered with Amazon Prime Now to test a two-hour delivery model in Dallas." They describe it as a test, and they hope to attract new customers. They say "While the program is still undergoing testing, we plan to work with Amazon to introduce Prime Now to other metropolitan cities, if it proves effective." This is about a partnership, but is it a case where management is reporting on Amazon's own expansion? No, it's about the company's own test and potential expansion. The counterparty is Amazon, but management is not describing Amazon's own trajectory as the driver; they are describing their own test. Also, it's early and uncertain. Another example: the loyalty program test in 300 stores. That's the company's own program, not a counterparty. The social media influencers: they host blogger events. That's their own marketing. The new brands: they are launching their own brands. The BSG business: they talk about new exclusive brands like Celeb Luxury, etc. Those are brands they are introducing, but they are not describing the counterparties' own growth trajectories. They are just listing new brands they have. Management also discusses the restructuring and cost savings, which is their own action.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.